RRC ID 65689
Author Sano K, Miki M, Tanaka T, Munemura M, Munekane M, Yamasaki T, Mukai T.
Title Electrostatically self-assembled gold nanorods with chondroitin sulfate for targeted photothermal therapy for melanoma.
Journal Photodiagnosis Photodyn Ther
Abstract BACKGROUND:The application of gold nanorods (GNRs) in photothermal therapy is a promising avenue for cancer treatment. The aim of this study was to develop a GNR-based targeted photothermal therapy for melanoma.
METHODS:We utilized the electrostatic interaction between cationic GNRs and an anionic polymer chondroitin sulfate A (CSA), which has an affinity for binding to melanoma cells, to construct an anionic binary GNR-CSA complex (GNR-CS) at an optimal theoretical charge ratio of the trimethylammonium groups of GNR: carboxyl and sulfate groups of CSA = 1:2.5. The cytotoxicity to normal cells and erythrocyte agglutination activity of GNR-CS were evaluated. After the cellular uptake of GNR-CS by melanoma cells (B16-F10) was investigated, the photothermal performance of GNR-CS against B16-F10 cells was evaluated in vitro.
RESULTS:The particle size and zeta potential of GNR-CS were approximately 35 nm and -20 mV, respectively. GNR-CS showed little cytotoxicity to normal cells and low erythrocyte agglutination activity, indicating good biocompatibility. Compared with negatively-charged GNR, GNR-CS was highly taken up by B16-F10 cells even if it was negatively charged. Cellular uptake was significantly suppressed upon treatment with excess CSA, suggesting the involvement of a CSA-specific uptake pathway. Furthermore, irradiation of the GNR-CS solution with near-infrared (NIR) light increased its temperature in light-intensity and GNR-concentration dependent manners. GNR-CS exhibited significant and GNR-dose dependent cytotoxicity in melanoma cells in combination with NIR light irradiation.
CONCLUSION:GNRs coated with CSA have the potential as a medicine in targeted photothermal therapy for melanoma.
Volume 35
Pages 102402
Published 2021-9-1
DOI 10.1016/j.pdpdt.2021.102402
PII S1572-1000(21)00229-5
PMID 34144259
MeSH Cell Line, Tumor Chondroitin Sulfates Gold Humans Melanoma* / drug therapy Nanotubes* Photochemotherapy* / methods Photosensitizing Agents / pharmacology Phototherapy Photothermal Therapy
IF 2.894
Resource
Human and Animal Cells RAW 264(RCB0535)